CW
ANIP icon

CreativeOne Wealth’s ANI Pharmaceuticals ANIP Stock Holding History

CreativeOne Wealth’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,418
Closed -$221K – 1179
2025
Q3 		$221K Buy
+2,418
New +$197K 0.01% 1060

Other funds holding ANIP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CreativeOne Wealth's ANIP Position: Q4 2025 in Review

CreativeOne Wealth sold out of ANI Pharmaceuticals (ANIP) in Q4 2025, closing a stake of 2,418 shares — an estimated $221K sold.

CreativeOne Wealth first reported a position in ANIP in Q3 2025 and held it in 1 quarter. The position peaked at $221K in Q3 2025. 284 funds tracked by Wall St. Rank hold ANIP as of Q4 2025.

  • CreativeOne Wealth reported no remaining ANI Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • CreativeOne Wealth sold 2,418 ANI Pharmaceuticals shares in Q4 2025, an estimated $221K.
  • CreativeOne Wealth first reported a position in ANI Pharmaceuticals in Q3 2025 and held it in 1 quarter.
  • CreativeOne Wealth's ANI Pharmaceuticals position peaked at $221K in Q3 2025.
  • 284 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q4 2025.

Based on CreativeOne Wealth's 13F filing for Q4 2025, filed 13 Feb 2026.